AMENDED AND RESTATED LOAN AGREEMENT Dated as of March 22, 2022 among COLLEGIUM PHARMACEUTICAL, INC. (as Borrower), THE GUARANTORS PARTY HERETO (as additional Credit Parties), BIOPHARMA CREDIT PLC (as Collateral Agent), BPCR LIMITED PARTNERSHIP (as a...Loan Agreement • March 23rd, 2022 • Collegium Pharmaceutical, Inc • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED LOAN AGREEMENT (this “Agreement”), dated as of March 22, 2022 by and among COLLEGIUM PHARMACEUTICAL, INC., a Virginia corporation (as “Borrower”), the Guarantors from time to time party hereto, BIOPHARMA CREDIT PLC, a public limited company incorporated under the laws of England and Wales with company number 10443190 (as the “Collateral Agent”), BPCR LIMITED PARTNERSHIP, a limited partnership established under the laws of England and Wales with registration number LP020944 (as a “Lender”) and BIOPHARMA CREDIT INVESTMENTS V (MASTER) LP, a Cayman Islands exempted limited partnership acting by its general partner, BioPharma Credit Investments V GP LLC (as a “Lender”), provides the terms on which each Lender shall make, and Borrower shall repay, the Credit Extensions (as hereinafter defined). This Agreement amends and restates in its entirety, and replaces, the terms of (and obligations outstanding under) that certain Loan Agreement, dated as of February 6, 2020 (
